Anticancer drug targets: cell cycle and checkpoint control.
作者信息
Shapiro G I, Harper J W
机构信息
Department of Adult Oncology and Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
出版信息
J Clin Invest. 1999 Dec;104(12):1645-53. doi: 10.1172/JCI9054.
Abstract
摘要
相似文献
1
Anticancer drug targets: cell cycle and checkpoint control.
J Clin Invest. 1999 Dec;104(12):1645-53. doi: 10.1172/JCI9054.
2
Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
Oncogene. 2002 Nov 21;21(53):8089-104. doi: 10.1038/sj.onc.1206000.
3
Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Exp Cell Res. 1995 Nov;221(1):92-102. doi: 10.1006/excr.1995.1356.
4
5
Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity.
Endocrinology. 1999 Nov;140(11):5267-74. doi: 10.1210/endo.140.11.7145.
6
Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1.
J Cell Biochem. 1994 Nov;56(3):418-25. doi: 10.1002/jcb.240560318.
7
Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints.
Clin Cancer Res. 2001 Nov;7(11):3629-39.
8
Role of proteasomes in T cell activation and proliferation.
J Immunol. 1998 Jan 15;160(2):788-801.
9
Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
Oncogene. 1998 Feb 5;16(5):587-96. doi: 10.1038/sj.onc.1201580.
引用本文的文献
1
Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective.
Cancer Rep (Hoboken). 2025 Sep;8(9):e70300. doi: 10.1002/cnr2.70300.
2
Anticancer Potential of Halogen Derivatives of Methyl 6-Acetyl-5-Hydroxy-2-Methyl-1-Benzofuran-3-Carboxylate.
Int J Mol Sci. 2025 Jun 8;26(12):5493. doi: 10.3390/ijms26125493.
3
Omaveloxolone Suppresses Cell Growth and Causes Cell Cycle Arrest by Downregulating CDC20 Expression in Glioblastoma Cells Both In Vitro and In Vivo.
J Cell Mol Med. 2025 Jun;29(11):e70607. doi: 10.1111/jcmm.70607.
4
Understanding therapeutic tolerance through a mathematical model of drug-induced resistance.
NPJ Syst Biol Appl. 2025 Apr 10;11(1):30. doi: 10.1038/s41540-025-00511-3.
5
Therapeutic Efficacy of Quercetin and Its Nanoformulation Both the Mono- or Combination Therapies in the Management of Cancer: An Update with Molecular Mechanisms.
J Trop Med. 2024 Oct 1;2024:5594462. doi: 10.1155/2024/5594462. eCollection 2024.
6
A novel amphiphilic squalene-based compound with open-chain polyethers reduces malignant melanoma metastasis in-vitro and in-vivo.
Cell Commun Signal. 2024 Sep 11;22(1):437. doi: 10.1186/s12964-024-01813-5.
7
Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells.
Cancers (Basel). 2024 Jul 23;16(15):2621. doi: 10.3390/cancers16152621.
8
Inhibiting AGS Cancer Cell Proliferation through the Combined Application of Aucklandiae Radix and Hyperthermia: Investigating the Roles of Heat Shock Proteins and Reactive Oxygen Species.
Antioxidants (Basel). 2024 May 3;13(5):564. doi: 10.3390/antiox13050564.
9
Facile sonochemically-assisted bioengineering of titanium dioxide nanoparticles and deciphering their potential in treating breast and lung cancers: biological, molecular, and computational-based investigations.
RSC Adv. 2024 Mar 14;14(12):8583-8601. doi: 10.1039/d3ra08908h. eCollection 2024 Mar 6.
10
Epigallocatechin-3-gallate Synergistically Enhanced Arecoline-Induced Cytotoxicity by Redirecting Cycle Arrest to Apoptosis.
Curr Issues Mol Biol. 2024 Feb 14;46(2):1516-1529. doi: 10.3390/cimb46020098.
本文引用的文献
1
Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy.
Int J Oncol. 1996 Dec;9(6):1143-68. doi: 10.3892/ijo.9.6.1143.
2
Chemical inhibitors of cyclin-dependent kinases.
Trends Cell Biol. 1996 Oct;6(10):393-7. doi: 10.1016/0962-8924(96)10034-9.
3
14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage.
Nature. 1999 Oct 7;401(6753):616-20. doi: 10.1038/44188.
4
UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent.
Oncogene. 1999 Sep 30;18(40):5691-702.
5
Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1.
Cell. 1999 Sep 17;98(6):859-69. doi: 10.1016/s0092-8674(00)81519-6.
6
RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.
Clin Cancer Res. 1999 Sep;5(9):2596-604.
7
Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.
Cancer Res. 1999 Sep 15;59(18):4634-41.
8
9
Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.
Cancer Res. 1999 Sep 1;59(17):4375-82.
10
CDK inhibitors: positive and negative regulators of G1-phase progression.
Genes Dev. 1999 Jun 15;13(12):1501-12. doi: 10.1101/gad.13.12.1501.
Zotero 插件